- Home
- Facial aesthetics
- Forehead and frown lines
- Botulinum toxin
Botulinum toxin: myths, risks and real results
Few aesthetic treatments generate as many opinions as botulinum toxin. It is a medicine with decades of use, heavily studied, with predictable results and side effects that are generally mild.

In this article
Few aesthetic treatments generate as many opinions as botulinum toxin. Some people are afraid because it is “a poison”, some fear ending up with a frozen face and some think that, once they start, they can never stop. The reality is simpler: it is a medicine with decades of use, heavily studied, with predictable results and side effects that are generally mild and temporary, as long as it is administered by doctors and in appropriate doses.
Three ideas to remember.
Myths and facts
| Myth | What the facts say |
|---|---|
| “It is a poison.” | At high doses, the toxin is dangerous. At medical doses, which are very small and applied to the right muscle, it has a well-known safety profile, with decades of use |
| “You end up with a frozen face.” | That happens with excessive or poorly distributed doses. With adjusted doses, the face keeps its expression |
| “Once you start, you cannot stop.” | You can stop at any time. The muscle recovers and the wrinkle returns to what it was |
| “It builds up in the body.” | No. The effect wears off because the nerve forms new connections to the muscle over weeks to months |
| “If you stop, the wrinkles get worse.” | There is no evidence of that. The wrinkle returns to the state it would have been in without treatment |
| “It is used for filling.” | No. The toxin relaxes muscles; it does not add volume. For volume, hyaluronic acid or biostimulators are used |
| “All brands are the same.” | The products have different doses and units, which are not directly interchangeable. Studies that compared them did not find clear differences in efficacy when used correctly |
How it works
For a muscle to contract, the nerve releases a substance called acetylcholine. Botulinum toxin blocks that release in the area where it is injected. The muscle relaxes, and the skin above stops folding. Over 3 to 4 months, the nerve regains the ability to communicate with the muscle, and movement returns.
Real results
- Area between the eyebrows: the most studied. In the trial that led to aesthetic approval, the toxin was superior to placebo at all assessments over four months (Carruthers et al., 2002).
- Forehead and crow’s feet: phase 3 trials show significant improvements compared with placebo (Carruthers et al., 2014; De Boulle et al., 2018).
- The evidence as a whole: the 2021 Cochrane review confirmed efficacy in facial wrinkles and noted that data are lacking on repeated treatments over the very long term (Camargo et al., 2021).
Risks
Frequent and mild
- Small bruises and tenderness at the injection points.
- Mild headache in the first days.
- Mild asymmetry, correctable at the review.
Uncommon
- Eyelid drooping, due to spread to the muscle that lifts it. It is temporary. In the original trial for the area between the eyebrows, it occurred in 5.4% of patients, almost always mild (Carruthers et al., 2002).
- Heavier or differently shaped eyebrows.
- Changes in the smile or in speech, when the area around the mouth is treated.
Rare
- Spread of the effect away from the treated site, with weakness, difficulty swallowing or speaking. This is the reason for the regulatory warning on these products (FDA, 2009). With aesthetic doses, it is very rare.
- Loss of response due to antibodies: the body can produce antibodies that neutralise the toxin. It is rare at aesthetic doses and more associated with high, repeated doses given at short intervals (Bellows and Jankovic, 2019).
Who should not have it
- Pregnant and breastfeeding women.
- People with neuromuscular diseases, such as myasthenia gravis.
- People taking certain medicines that interact with the toxin, such as certain aminoglycoside antibiotics.
- People with an active infection in the area to be treated.
How to reduce the risks
- Have the treatment done by a doctor, who knows the anatomy and can respond to complications.
- Be wary of very low prices or products of unclear origin.
- Respect intervals of at least 3 months between treatments.
- Follow the instructions for the first hours: do not massage the area or lie down.
- Have a review after about two weeks.
At Luxmed Clinic
At Luxmed, we use botulinum toxin with doses adjusted to each face and each muscle. We explain what to expect and the real risks, and we do a review after two weeks. We prefer natural results to expressionless faces.
Talk to us
The assessment is a conversation, with no obligation. Tell us what concerns you and our team will reply.
This article is for information only and does not replace a consultation. The results of any treatment vary from person to person. Botulinum toxin is a prescription-only medicine and should only be administered by doctors.
Frequently asked questions
From what age can it be done?
In aesthetics, in adults. More than age, what counts is having a wrinkle that bothers you and a clear indication.
Does the effect decrease over time?
In general, no. If the response clearly decreases, it should be investigated, for example for the possibility of antibodies or an insufficient dose.
Can I exercise on the same day?
It is recommended to avoid intense exercise in the first hours, to reduce the risk of the product spreading.
Do men need different doses?
Often, yes, because the muscles tend to be stronger. The dose is always individual.
Is it true that it prevents wrinkles?
Reducing repeated contraction can delay the wrinkles from becoming marked, but the long-term evidence is limited. There is a dedicated article on preventive toxin: Preventive botulinum toxin: what the evidence says.
Scientific references 6
- Carruthers JA, Lowe NJ, Menter MA, et al. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol. 2002;46(6):840-849. Artigo
- Camargo CP, Xia J, Costa CS, et al. Botulinum toxin type A for facial wrinkles. Cochrane Database Syst Rev. 2021;7:CD011301. Revisão Cochrane
- Carruthers A, Bruce S, de Coninck A, et al. Efficacy and safety of onabotulinumtoxinA for the treatment of crow's feet lines: a multicenter, randomized, controlled trial. Dermatol Surg. 2014;40(11):1181-1190. Artigo
- De Boulle K, Werschler WP, Gold MH, et al. Phase 3 study of onabotulinumtoxinA distributed between frontalis, glabellar complex, and lateral canthal areas for treatment of upper facial lines. Dermatol Surg. 2018;44(11):1437-1448. Artigo
- U.S. Food and Drug Administration. Information for healthcare professionals: botulinum toxin products, distant spread of toxin effect. 2009. Site
- Bellows S, Jankovic J. Immunogenicity associated with botulinum toxin treatment. Toxins (Basel). 2019;11(9):491. Artigo
Keep exploring

